PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $62.70 | -4.4% | -13.8% | -27.5% | -1.3% | +10.1% | +128.3% | +70.3% | |
| TTM Revenue | $67.67M | -36.0% | – | -36.0% | – | -21.1% | +580.0% | +17.1% | |
| TTM EPS | -$7.22 | -5.5% | – | -5.5% | – | -41.0% | -26.9% | -230.4% | |
| -50.24 | +4.4% | +13.8% | +25.8% | -324.3% | -276.3% | -733.2% | -505.5% | ||
| 128.81 | -4.4% | -13.8% | -25.8% | +45.2% | +61.5% | -61.9% | -10.0% | ||
| $8.82B | -4.4% | -13.6% | -25.6% | +7.4% | +22.7% | +209.1% | +209.7% | ||
| -12.68 | +4.4% | +13.7% | +25.5% | +7.0% | +0.6% | -116.0% | +13.8% | ||
| Market Cap | $9B | -4.4% | -13.8% | -25.8% | +11.6% | +25.3% | +229.7% | +182.5% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 850.00 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 5.93 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 36.82 | +431.3% |
| Date | Value | Change |
|---|---|---|
| 6.93 | - |
Formula
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk
